1. Home
  2. SRTA vs BWAY Comparison

SRTA vs BWAY Comparison

Compare SRTA & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SRTA

Strata Critical Medical Inc.

N/A

Current Price

$5.54

Market Cap

530.4M

Sector

N/A

ML Signal

N/A

Logo BrainsWay Ltd.

BWAY

BrainsWay Ltd.

N/A

Current Price

$11.12

Market Cap

446.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SRTA
BWAY
Founded
2014
2003
Country
United States
Israel
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
530.4M
446.4M
IPO Year
2019
2011

Fundamental Metrics

Financial Performance
Metric
SRTA
BWAY
Price
$5.54
$11.12
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
3
Target Price
$9.56
★ $19.27
AVG Volume (30 Days)
★ 1.1M
85.4K
Earning Date
11-03-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 242.86
N/A
EPS
N/A
★ N/A
Revenue
★ $197,141,000.00
N/A
Revenue This Year
$47.51
$32.42
Revenue Next Year
$12.14
$23.40
P/E Ratio
★ N/A
$81.98
Revenue Growth
N/A
★ N/A
52 Week Low
$3.95
$10.94
52 Week High
$6.50
$26.63

Technical Indicators

Market Signals
Indicator
SRTA
BWAY
Relative Strength Index (RSI) 67.17 41.15
Support Level $4.98 N/A
Resistance Level $5.64 $12.12
Average True Range (ATR) 0.29 0.44
MACD 0.12 0.01
Stochastic Oscillator 93.95 32.98

Price Performance

Historical Comparison
SRTA
BWAY

About SRTA Strata Critical Medical Inc.

Strata Critical Medical Inc is a time-critical logistics and medical services provider to the U.S. healthcare industry. The group operates one of the nation's air transport and surgical services networks for transplant hospitals and organ procurement organizations, offering an integrated 'One Call' solution for donor organ recovery. It includes two segments: Logistics segments which hold, Air Logistics, Ground Logistics and Organ Placement. The second segment is Clinical Segment which includes: Organ Recovery, Normothermic Regional Perfusion (NRP), and Preservation, and Other Clinical Segment which has Cardiac Care, and Other.

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

Share on Social Networks: